Developer of allogeneic cellular immunotherapies designed for advancing cancer treatment. The company's immunotherapies utilize proprietary expansion technology to amplify cord blood-derived immune st...

Healthcare
San Francisco, CA, United States
Founded 2018
19 employees
Website
Valuation
$11M
Latest known
Share Price
N/A
Total Raised
$17.6M
Last Round
N/A